Teaching pharmacotherapeutics to family medicine residents: a curriculum.
(49/152)
PROBLEM BEING ADDRESSED: Medication prescribing is becoming increasingly complex, and the need for formal curricula in pharmacotherapeutics and medication prescribing in accredited family medicine residency programs has been advocated. OBJECTIVE OF PROGRAM: The main objective of the pharmacotherapeutic curriculum is to support the development of family medicine residents' pharmacotherapeutic knowledge and medication prescribing skills required for rational prescribing. PROGRAM DESCRIPTION: The curriculum has 4 main components: 1) a medication prescribing framework based on the main tasks and key decisions related to the prescribing of medications, 2) 12 pharmacotherapeutic topics identified in the needs assessment, 3) a 5-step process for session design used by the curriculum development team, and 4) a description of specific roles of facilitators involved in delivering the curriculum. Formative evaluation of the curriculum using resident focus groups has helped to inform the further development of its components. CONCLUSION: A formalized curriculum was created to build knowledge of pharmacotherapeutics and effective medication prescribing skills, which are necessary for the current complex environment of patient care and medication management. (+info)
Are pragmatic studies pragmatic? Proceedings from a symposium at the third annual Canadian Therapeutics Congress--May 2006, Toronto.
(50/152)
A multi-stakeholder symposium at the third annual Canadian Therapeutics Congress (May 2006) discussed the nature of pragmatic studies, and helped to further define their role in the drug regulatory system, formulary access decisions and in clinical practice. The symposium panel appeared to have agreed that pragmatic studies were beneficial, but revealed differences in how, when and where they should be done. (+info)
What's new in clinical pharmacology and therapeutics.
(51/152)
The US Food and Drug Administration (FDA) has approved several new drugs in the past 2 years. This article provides an overview of some of the newer drugs that are likely to find wider use in the future. The drugs reviewed in this article can be used to treat cardiovascular system problems, diabetes mellitus, multiple sclerosis, hepatitis B infection, hyponatremia, Parkinson's disease, rheumatoid arthritis, pain, constipation, and insomnia. Another drug discussed can be used to help a patient stop smoking. The article also discusses Gardasil, the recombinant vaccine against human papilloma virus (types 6, 11, 16, and 18). (+info)
Pandemic and seasonal influenza: therapeutic challenges.
(52/152)